Related Experiment Video

Updated: Feb 13, 2026

Endoscopic Ultrasound-Guided Biliary Drainage: Endoscopic Ultrasound-Guided Hepaticogastrostomy in Malignant Biliary Obstruction

Endoscopic Ultrasound-Guided Biliary Drainage: Endoscopic Ultrasound-Guided Hepaticogastrostomy in Malignant Biliary Obstruction

Published on: March 25, 2022

Medical management and endoscopic biliary stenting associated with improved outcomes compared with surgery for

Jay Pakhawala¹, Allyson Berent², Chick Weisse²

¹1Department of Internal Medicine, The Schwarzman Animal Medical Center, New York, NY.

Journal of the American Veterinary Medical Association

|February 11, 2026

Abstract

Objective:

To compare short- and long-term clinical outcomes in dogs with extrahepatic biliary duct obstruction (EHBO) managed medically, with endoscopic retrograde cholangiography (ERC)-assisted biliary stenting, or with surgical biliary decompression.

Methods:

Medical records from 28 client-owned dogs diagnosed with EHBO and treated at a single veterinary referral center between 2012 and 2019 were reviewed retrospectively as part of an observational study. Inclusion criteria included common bile duct dilation (> 3 mm) and clinicopathologic evidence of biliary obstruction. Dogs were grouped based on treatment modality: medical management, ERC (ERC-assisted biliary stenting), or surgery. Outcomes included survival to discharge, median survival time, and complications.

Results:

28 dogs were included: 10 medically managed, 12 treated with ERC-assisted biliary stenting, and 6 treated surgically. Survival to discharge was 100% (medical), 92% (ERC), and 33% (surgical). Median survival time was not reached in medical or ERC groups; the surgical group had a median survival time of 4 days. Endoscopic retrograde cholangiography achieved technical success in 86% of cases and had a lower complication rate than surgery. Most dogs managed medically experienced spontaneous resolution of EHBO with supportive care. Pancreatitis as the cause of EHBO was associated with not surviving to discharge.

Conclusions:

Medical management and ERC-assisted biliary stenting were associated with improved short- and long-term survival rates and fewer complications compared to surgical intervention. Surgical intervention was associated with the highest mortality and complication rates.

Clinical Relevance:

ERC-assisted biliary stenting and medical management may provide safer alternatives for similar etiologies to surgery for dogs with EHBO, particularly in facilities with interventional endoscopic capabilities. In many cases, supportive care alone may lead to spontaneous resolution of EHBO.

Keywords:

biliary decompression biliary stenting canine endoscopic retrograde cholangiography extrahepatic biliary duct obstruction

More Related Videos

Laparoscopic Common Bile Duct Exploration in Patients with a Previous History of Biliary Tract Surgery

Laparoscopic Common Bile Duct Exploration in Patients with a Previous History of Biliary Tract Surgery

Published on: February 10, 2023

Extrahepatic Bile Duct and Gall Bladder Dissection in Nine-Day-Old Mouse Neonates

Extrahepatic Bile Duct and Gall Bladder Dissection in Nine-Day-Old Mouse Neonates

Published on: August 23, 2022

Related Concept Videos

Endocarditis III: Medical Management

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...

Myocarditis III: Medical Management

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...

Pericarditis III: Medical Management

Pericarditis III: Medical Management

The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...

Heart Failure V: Medical Management

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...

Mitral Stenosis III: Medical Management

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...

Aortic Regurgitation III: Medical Management

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...

Articles linked to this work by shared authors, journal, and citation graph.

Use of a graphic design for oncology discharge instructions is preferred by pet owners over text-only instructions with identical readability.

Journal of the American Veterinary Medical Association·2026

Neuron-specific WWOX gene therapy produces dose-dependent, durable rescue in a model of WWOX-related epileptic encephalopathy.

Molecular therapy. Advances·2026

Off-label use of dapagliflozin in a dog with recurrent calcium oxalate urolithiasis: a case report.

BMC veterinary research·2026

Perirenal lipoma in a 14-year-old spayed female dog: A rare diagnosis.

The Canadian veterinary journal = La revue veterinaire canadienne·2026

Prevalence of tracheal collapse syndrome, congenital portosystemic shunts, or both in Yorkshire Terriers at one veterinary hospital.

Journal of veterinary internal medicine·2026

Evaluating different scoring algorithms to assess communication ability for individuals living with Angelman syndrome: the Observer-Reported Communication Ability (ORCA) measure.

Journal of patient-reported outcomes·2026

See all related articles